FOSTER CITY, Calif. - Gilead Sciences, Inc. (NASDAQ:GILD), a biopharmaceutical firm with a market capitalization of $119.87 billion, announced today a 2.6% increase in its quarterly cash dividend.

While many Canadian stocks are trading at 52-week highs, these two top TSX stocks are undervalued, making them among the best ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...

For example, the recent F share price of $9.24 represents a price-to-book ratio of 0.8 and an annual dividend yield of 6.49% ...

Dividend growth investing is a proven, low-risk strategy for building wealth. Check out my four dividend growth stock picks ...

The company's announcement that it was walking back its 2028 goals for smoke-free products warranted a closer look at its ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

Star Group continues to outperform with volume gains and solid earnings. See why SGU stock’s 12.16% return projection makes ...

(Reuters) - Netflix is considering a bid for Formula One's U.S. TV rights, according to a report from The Athletic on Friday.

Key Insights The projected fair value for Thakral is S$0.91 based on Dividend Discount Model Current share price ...

But making Archer Daniels Midland even more interesting is the fact that on Wednesday, shares of ADM entered into oversold ...

Entergy's estimated fair value is US$79.49 based on Dividend Discount Model. With US$81.66 share price, Entergy appears to be trading close to its estimated fair val ...